7-(3,5-dimethyl-1,2-oxazol-4-yl)-6-methoxy-N-[(1R)-1-pyridin-2-ylethyl]-9H-pyrimido[4,5-b]indol-4-amine
C23H22N6O2 — CID 129214093
Data last refreshed: (MolForge compound catalog, from PubChem)
About 7-(3,5-dimethyl-1,2-oxazol-4-yl)-6-methoxy-N-[(1R)-1-pyridin-2-ylethyl]-9H-pyrimido[4,5-b]indol-4-amine
7-(3,5-dimethyl-1,2-oxazol-4-yl)-6-methoxy-N-[(1R)-1-pyridin-2-ylethyl]-9H-pyrimido[4,5-b]indol-4-amine (PubChem CID 129214093) has the molecular formula C23H22N6O2 and a molecular weight of 414.47 g/mol. Its IUPAC name is 7-(3,5-dimethyl-1,2-oxazol-4-yl)-6-methoxy-N-[(1R)-1-pyridin-2-ylethyl]-9H-pyrimido[4,5-b]indol-4-amine.
Molecular Properties
| Compound Name | 7-(3,5-dimethyl-1,2-oxazol-4-yl)-6-methoxy-N-[(1R)-1-pyridin-2-ylethyl]-9H-pyrimido[4,5-b]indol-4-amine |
|---|---|
| PubChem CID | 129214093 |
| Molecular Formula | C23H22N6O2 |
| Molecular Weight | 414.47 g/mol |
| Exact Mass | 414.18 |
| IUPAC Name | 7-(3,5-dimethyl-1,2-oxazol-4-yl)-6-methoxy-N-[(1R)-1-pyridin-2-ylethyl]-9H-pyrimido[4,5-b]indol-4-amine |
| SMILES | COc1cc2c(cc1-c1c(C)noc1C)[nH]c1ncnc(N[C@H](C)c3ccccn3)c12 |
| InChI | InChI=1S/C23H22N6O2/c1-12(17-7-5-6-8-24-17)27-22-21-15-10-19(30-4)16(20-13(2)29-31-14(20)3)9-18(15)28-23(21)26-11-25-22/h5-12H,1-4H3,(H2,25,26,27,28)/t12-/m1/s1 |
| InChIKey | UJQGMCKJOYFQAO-GFCCVEGCSA-N |
| XLogP | 4.96 |
| TPSA | 101.75 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 31 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 414.47 |
| LogP ≤ 5 | 4.96 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 7 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 129214093 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.